US president orders review of all pre-emption rules issued in last ten years
This article was originally published in RAJ Devices
US president Barack Obama wants a review of all federal regulations issued in the last ten years that intend to pre-empt individual state laws, to ascertain whether these were issued with sufficient legal basis1. The review could have major implications for the medical technology industry, which has long favoured “uniform regulations” to increase the certainty of the regulatory process and to avoid facing product liability suits under state laws2.
You may also be interested in...
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.
A damning UK report makes uncomfortable reading about how thousands of women suffered avoidable harm from the anti-epileptic drug sodium valproate and two other medical interventions and how safety concerns raised were dismissed, overlooked and ignored.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.